Literature DB >> 15826177

Chemistry of the diazeniumdiolates: Z right harpoon over left harpoon E isomerism.

Yan-Ni Wang1, D Scott Bohle, Challice L Bonifant, Gwendolyn N Chmurny, Jack R Collins, Keith M Davies, Jeffrey Deschamps, Judith L Flippen-Anderson, Larry K Keefer, John R Klose, Joseph E Saavedra, David J Waterhouse, Joseph Ivanic.   

Abstract

Here, we explore the chemistry of the previously undocumented E form of diazeniumdiolates having the structure R(1)R(2)NN(O)=NOR(3). Reported crystallographic studies have uniformly revealed the Z configuration, and our attempts to observe a Z --> E conversion through thermal equilibration or photochemical means have, until now, consistently failed to reveal a significant amount of a second conformer. As a typical example, the NMR spectrum of trimethyl derivative Me(2)NN(O)=NOMe revealed no evidence for a second configuration. Electronic structure calculations attribute this finding to a prohibitively high interconversion barrier of approximately 40 kcal/mol. A similar result was obtained when we considered the case of R(1) = Me = R(3) and R(2) = H at the same levels of theory. However, when MeHNN(O)=NOMe was ionized by dissociating the N-H bond, the barrier was calculated to be lower by approximately 20 kcal/mol, with the E form of the anion being favored over Z. This circumstance suggested that an E isomer might be isolable if a Z anion were formed and given sufficient time to assume the E configuration, then quenched by reaction with an electrophile to trap and neutralize the E form and restore the putatively high interconversion barrier. Consistent with this prediction, basifying iPrHNN(O)=NOCH(2)CH(2)Br rapidly led to a six-membered heterocycle that was crystallographically characterized as containing the -N(O)=NO- functional group in the E configuration. The results suggest an approach for generating pairs of Z and E diazeniumdiolates for systematic comparison of the rates at which the individual isomers release bioactive NO and of other physicochemical determinants of their biomedical utility.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15826177     DOI: 10.1021/ja042258l

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  7 in total

1.  High-level theoretical study of the NO dimer and tetramer: has the tetramer been observed?

Authors:  Joseph Ivanic; Michael W Schmidt; Brian Luke
Journal:  J Chem Phys       Date:  2012-12-07       Impact factor: 3.488

2.  Decoding nitric oxide release rates of amine-based diazeniumdiolates.

Authors:  Yan-Ni Wang; Jack Collins; Ryan J Holland; Larry K Keefer; Joseph Ivanic
Journal:  J Phys Chem A       Date:  2013-07-23       Impact factor: 2.781

3.  Novel protection-deprotection strategies in diazeniumdiolate chemistry: synthesis of V-IPA/NO.

Authors:  Rahul S Nandurdikar; Larry K Keefer; Joseph E Saavedra
Journal:  Chem Commun (Camb)       Date:  2011-05-10       Impact factor: 6.222

4.  Dual mechanisms of HNO generation by a nitroxyl prodrug of the diazeniumdiolate (NONOate) class.

Authors:  Daniela Andrei; Debra J Salmon; Sonia Donzelli; Azadeh Wahab; John R Klose; Michael L Citro; Joseph E Saavedra; David A Wink; Katrina M Miranda; Larry K Keefer
Journal:  J Am Chem Soc       Date:  2010-10-29       Impact factor: 15.419

5.  O2-functionalized methylamine diazeniumdiolates: evidence for E ⇄ Z equilibration in an acyclic system.

Authors:  Debanjan Biswas; Ryan J Holland; Jeffrey R Deschamps; Zhao Cao; Larry K Keefer; Joseph E Saavedra
Journal:  J Org Chem       Date:  2012-11-20       Impact factor: 4.354

Review 6.  Fifty years of diazeniumdiolate research. From laboratory curiosity to broad-spectrum biomedical advances.

Authors:  Larry K Keefer
Journal:  ACS Chem Biol       Date:  2011-09-30       Impact factor: 5.100

7.  Aminolysis of an N-diazeniumdiolated amidine as an approach to diazeniumdiolated ammonia.

Authors:  Debanjan Biswas; Joseph A Hrabie; Joseph E Saavedra; Zhao Cao; Larry K Keefer; Joseph Ivanic; Ryan J Holland
Journal:  J Org Chem       Date:  2014-05-05       Impact factor: 4.354

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.